School of Medicine
Showing 10,401-10,500 of 13,019 Results
-
Linxi Shi
Sr Res Scientist-Physical, Rad/Radiological Sciences Laboratory
BioI am a medical physicist and imaging scientist with over a decade of experience in CT imaging, algorithm development, and AI-driven reconstruction. I earned my Ph.D. in Medical Physics from the Georgia Institute of Technology, where I developed novel artifact corrections and reconstruction algorithms for cone beam computed tomography, focusing on applications in breast cancer diagnosis and image-guided radiation therapy.
Following my doctoral studies, I completed a postdoctoral fellowship with the Stanford Cancer Imaging Training (SCIT) Program. Currently, I serves as a Senior Research Scientist in the Radiological Sciences Laboratory at Stanford University. My research focuses on developing advanced clinical translational x-ray and CT imaging systems, including algorithm design for tomographic reconstruction, artifact correction, and image processing for various imaging modalities. -
Run Zhang Shi
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsClinical chemistry and therapeutic drug monitoring;
adult and pediatric clinical endocrine testing;
screening, detection and follow up of multiple myeloma;
tumor markers;
clinical utility of tandem mass spectrometry and high resolution mass spectrometry. -
Junming Seraphina Shi
Postdoctoral Scholar, Radiation Biology
BioI am a postdoctoral fellow at Stanford University, jointly mentored by Dr. Mohammad Shahrokh Esfahani and Dr. Md Tauhidul Islam. My research focuses on developing robust statistical machine learning methods for noninvasive, cost-effective cancer diagnostics, with applications in early detection, treatment monitoring, and precision oncology.
I received my Ph.D. from UC Berkeley, where my dissertation centered on advancing biostatistical machine learning approaches for complex biomedical challenges. My work addressed causal inference for continuous treatments, bias and measurement patterns in ICU electronic health records, and deep learning–based biclustering and prediction of cancer-drug responses. Across these projects, I developed interpretable and scalable tools for analyzing high-dimensional, multimodal clinical data.
At Stanford, I continue to build novel statistical learning frameworks tailored to real-world clinical needs—particularly through the analysis of liquid biopsy (cell-free DNA) and cancer imaging data. My current work aims to improve cancer detection and monitoring, with a focus on noninvasive, accessible, and clinically meaningful solutions to pressing challenges in oncology. I enjoy interdisciplinary collaborations and working across fields to drive innovation in biomedical research. Deeply committed to cancer research, I aim to bridge rigorous computational methodology with patient-centered impact by designing tools that are scalable, equitable, and translational. -
Vivian Shih, MD
Clinical Associate Professor, Orthopaedic Surgery
BioDr. Vivian Shih received her Bachelor of Science with honors and Doctor of Medicine degree from the University of Miami. In 2002, she completed her postgraduate medical training in Physical Medicine and Rehabilitation at the Feinberg School of Medicine at Northwestern University and the Rehabilitation Institute of Chicago (Shirley Ryan Ability Lab). She is board certified in Physical Medicine and Rehabilitation (PM&R or Physiatry) and specializes in non-surgical management of musculoskeletal disorders, arthritis, gait and balance disorders. She also performs electrodiagnostic testing (EMG/NCS), ultrasound guided joint/soft tissue injections, and platelet rich plasma (PRP) injections. Dr. Shih previously practiced in the New Haven area from 2005 to 2018. She was an Attending Physician at Yale-New Haven Hospital and on faculty at the Yale School of Medicine. Prior to that, she had been practicing at Northwestern University Medical Center and the Rehabilitation Institute of Chicago. She has published in the Arthritis and Rheumatism journal, Academy of Physical Medicine & Rehabilitation (AAPM&R) online review, Archives of Physical Medicine and Rehabilitation journal, and Koopman's Arthritis and Allied Health textbook. She is a member of the AAPM&R, Association of Academic Physiatrists (AAP), and the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM).
-
Hiroyuki Shimada
Professor of Pathology and, by courtesy, of Pediatrics
BioHiroyuki Shimada, MD, PhD, FRCPA (Hon), is Professor of Pathology and of Pediatrics at the Stanford University Medical Center. He was born in Tokyo, Japan, and completed MD (1973) and PhD (1982) at the Yokohama City University School of Medicine, Yokohama, Japan, and also completed his pathology training at the Children's Hospital (now the Nationwide Children’s Hospital) and the Ohio State University, Columbus, Ohio, USA (1988). Before moving to the Stanford University in 2019, he was Professor of Pathology (Clinical Scholar) at the University of Southern California Keck School of Medicine and working at the Children’s Hospital Los Angeles.
Dr. Shimada was Chair of the International Neuroblastoma Pathology Committee (1999-2017) and the founder of the International Neuroblastoma Pathology Classification (INPC). As Director of the COG (Children’s Oncology Group) Neuroblastoma Pathology Reference Laboratory (since 2001), he has been actively reviewing pathology samples of ~700 neuroblastoma cases per year from United States, Canada, Australia, and New Zealand. Pathology review results according to the INPC have been providing critical information for patient stratification and protocol assignment in the COG international neuroblastoma clinical trials. -
Andrew Young Shin
Clinical Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsSURF PROGRAM
The SURF program is an innovative collaboration between LPCH, Stanford University Hospital and the Stanford School of Engineering. The program has focused on improving quality and safety of patient care, improving hospital operations and promoting clinical effectiveness utilizing contemporary technologies such as machine learning, mathematical optimization, simulation and a variety of statistical, probabilistic and computational tools. The program has 2 independent funding mechanism to primarily improve patient care/hospital operations and improve academics for faculty within the department of Pediatrics at LPCH.
https://surf.stanford.edu/
CLINICAL EFFECTIVENESS
The Clinical Effectiveness (CE) Program is a funded program that aims to understand and improve unnecessary variation in healthcare delivery in order to optimize quality of care and reduce wasteful expenditures. The CE program has developed innovative programs such as Target Based Care, an award-winning intervention to reduce variation in hospital length of stay and currently a multi-center trial involving more than 20 hospitals in North America. In 2016, the CE program included the first CE fellowship program in a pediatric training program with 3 cycles of graduates. The CE program is supported by LPCH and a philanthropic gift by Susan Choe and Thomas Tobiason. -
Parveen Shiraz, MD
Instructor, Medicine - Blood & Marrow Transplantation
Current Research and Scholarly InterestsI am a physician-scientist in the Division of Blood and Marrow Transplantation-Cell Therapy (BMT-CT) at Stanford University. The focus of my laboratory research is the exploration of safe and more accessible forms of cell therapy for myeloid malignancies. We are studying multi-antigen targeting antibodies and engineered Natural Killer cells for myeloid malignancies.
-
Judith Shizuru
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsTransplantation of defined populations of allogeneic hematopoietic cells. Specifically, the way in which hematopoietic cell grafts alter antigen specific immune responses to allo-, auto- and viral antigens. The cellular and molecular basis of resistance to engraftment of allogeneic hematopoietic stem cells.
-
Eugene Shkolyar, MD
Clinical Assistant Professor, Urology
BioEugene Shkolyar, MD is a urologic oncologist who specializes in treating patients with bladder, prostate, kidney, and testis cancers. He is a clinical assistant professor in the Department of Urology at the Stanford School of Medicine.
Dr. Shkolyar has expertise in open, endoscopic, and robotic surgery and in caring for patients with complex urologic oncology needs. Dr. Shkolyar is actively engaged in translational research, with a particular interest in integrating artificial intelligence into bladder cancer treatment and the development of novel biomarkers for cancer detection. His commitment to continual innovation ensures that his patients have access to the latest and most effective treatment options.
Dr. Shkolyar was born in Kyiv, Ukraine, and raised in New York. He attended Cornell University for his undergraduate education and went on to UCLA for medical school. Following medical school, Dr. Shkolyar completed a residency in urology at Stanford, where he developed his interest in urologic oncology, translational bladder cancer research and teaching. He went on to complete a two-year fellowship in urologic oncology at Stanford School of Medicine gaining additional skills in management of complex urologic cancers. Dr. Shkolyar is the recipient of numerous honors and awards, including membership in the Alpha Omega Alpha medical honors society and a research scholar award from the Urology Care Foundation. In addition, he has authored and co-authored numerous publications in urology, artificial intelligence, and device development.
Dr. Shkolyar is a member of the Society of Urologic Oncology, the American Society of Clinical Oncology, the American Urological Association, and the European Association of Urology. -
Mir S Adil
Postdoctoral Scholar, Cardiology
BioDr. Adil is a Postdoctoral Scholar at RabLab in the cardiopulmonary division. He has a PharmD from Jawaharlal Nehru Technological University Hyderabad (India) and a PhD in Clinical & Experimental Therapeutics from University of Georgia. He has a pre-doctoral experience of three years as a Scientific Writer, Clinical Research Co-ordinator and Clinical Pharmacologist. He has also worked as a Research Pharmacologist at Charlie Norwood VA Medical Center during his PhD. He has served as a Consulting Editor for Dove Medical Press Journals and he has been serving as Editor, Editorial Board Member and Reviewer for several other journals. He has nearly 50 peer-reviewed publications to his name that include book chapters, review and research articles. Besides publications, he has reviewed more than 20 manuscripts for some reputed journals.
-
Zahra Shokri Varniab
Postdoctoral Scholar, Radiology
BioZahra Shokri Varniab, MD, studied medicine at Tehran University of Medicine Sciences, Iran, and earned her medical degree in 2020. Her goal in novel cellular and molecular imaging is to develop novel in vivo imaging approaches to visualize, characterize and quantify molecular and cellular processes involved in developing brain tumors. She intends to utilize non-invasive imaging techniques to assess tumor microenvironment to understand their role in cancer, develop a method for determining tumor profiles, and also using brain MR Imaging to assess treatment response. She hopes cancer to be history.
-
William Shomali
Clinical Assistant Professor, Medicine - Hematology
BioDr. Shomali is a clinical assistant professor of Hematology at Stanford University School of Medicine. He is board certified in hematology & medical oncology.
Dr. Shomali specializes in the treatment of blood cancers such as myeloproliferative neoplasms and myelodysplastic syndromes. He aims to provide compassionate, personalized, and evidence-based care to each patient.
Dr. Shomali received his medical degree from the University of Jordan, followed by a postdoctoral fellowship at MD Anderson Cancer Center where he studied infections in cancer patients and the role of biomarkers in defining tumor fever. He completed his residency training in Internal Medicine at the Cleveland Clinic Foundation where he served as a Chief Medical Resident. He then joined Stanford University for his combined Hematology & Oncology fellowship training.
Dr. Shomali’s research interests include the study of novel agents in myeloproliferative neoplasms and myelodysplastic syndromes. He developed investigator-initiated clinical trials for patients with eosinophilic neoplasms and advanced myelofibrosis. In addition, he co-authored several papers and book chapters discussing the care of patients with cancer. His work has been presented in national meetings and published in peer reviewed journals including Blood, American Journal of Hematology, British Journal of Hematology, Leukemia & Lymphoma, and Cancer.
Among his honors, Dr. Shomali received the Cleveland Clinic Excellence in Teaching Award and was named to the Alpha Omega Alpha Medical Honor Society. He has received a Young Investigator Award from the Conquer Cancer Foundation, an NIH Institutional National Research Service Award, and a Stanford Cancer Institute Fellowship Award.
Dr. Shomali is a member of the American Society of Hematology and the American Society of Clinical Oncology. -
Mahasish Shome
Postdoctoral Scholar, Genetics
BioDr. Mahasish Shome is interested in understanding the underlying mechanism of disease progression. He uses various omics profiling to identify biomarkers relevant to the disease. He studies antibodies, cytokines, proteins and metabolites profile to decipher the connection of disease with markers. This helps in early diagnosis, understanding disease state and drug/vaccine effectiveness.
-
Stanford Shoor
Clinical Professor, Medicine - Immunology & Rheumatology
Current Research and Scholarly InterestsPatient Centered Care in Rheumatic Disease
Sarcoidosis -
Jade Shorter, MD, MSHP
Clinical Associate Professor, Obstetrics & Gynecology
BioDr. Shorter specializes in complex family planning, early pregnancy management, and general gynecology. She is committed to improving the continuity of care for patients with early pregnancy complications and serves as the Director of the Early Pregnancy Assessment Program. Her clinical research interests include improving patients’ experience with abortion and early pregnancy care, addressing reproductive health disparities, and promoting health equity.
-
Linda M. Dairiki Shortliffe
Stanley McCormick Memorial Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsThe timing for intervention in obstruction in the infant and child is poorly understood.Our group has been interested in trying to define the risks that may be involved in obstructive and infectious uropathies and discovering early signs of damage to the urinary tract and kidney. We have explored ways of imaging the urinary tract using nonionizing radiation (US, MRI). We have studied the relationships of sex steroid hormones, pregnancy, reflux, urinary tract infection and urinary tract function.
-
Joseph Shrager
Professor of Cardiothoracic Surgery
On Leave from 02/03/2025 To 05/30/2025Current Research and Scholarly InterestsIn clinical research, Dr. Shrager studies outcomes in a variety of areas within Thoracic Surgery including: parenchyma-sparing operations and minimally invasive resections for lung cancer, transcervical thymectomy for myasthenia gravis, diaphragm plication, and surgical treatment of emphysema.
Dr. Shrager's lab is focused on the impact of disease states upon the diaphragm. His group published the seminal paper (NEJM) describing diaphragm atrophy assoc'd with mechanical ventilation. -
Aimee D. Shu
Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioI am an endocrinologist with particular interests in reproductive and bone health.
I enjoy treating patients with menstrual disorders, menopause, fractures, osteoporosis, parathyroid imbalance, and calcium imbalance.
As a certified menopause practitioner (North American Menopause Society), I help women fine-tune their health at the mid-life transition. Some women transition through menopause with ease, while others experience challenging symptoms like hot flashes, slowed metabolism, and mood changes. This transition period provides a good opportunity to create a "game plan" for preserving future health. It also marks the beginning of natural bone loss, leaving one more susceptible to fragility fractures.
I provide individualized treatment plans for bone health to men and women of all ages, including for those with specific challenges such as chronic steroid use. As a certified clinical densitometrist (International Society for Clinical Densitometry), I personally review all my patients' bone density scan images. Thus, please bring any non-Stanford bone density scan images to your appointment with me.
Appointments with me are available on Stanford's main campus (300 Pastuer Drive) and at the Stanford Medicine Outpatient Center (450 Broadway, Redwood City). -
Yasuhiro Shudo, MD, PhD
Clinical Associate Professor, Cardiothoracic Surgery
BioDr. Shudo is a board-certified cardiothoracic surgeon and clinical associate professor in the Department of Cardiothoracic Surgery at Stanford University School of Medicine.
His clinical focus is the surgical treatment of end-stage cardiopulmonary failure, including heart transplant, heart-lung transplant, lung transplant, mechanical circulatory support (MCS), and extracorporeal membrane oxygenation (ECMO). He has published numerous landmark papers
and chapters.
Dr. Shudo also performs mitral valve repair/replacement (MVR), aortic valve replacement (AVR), complex valve surgery, coronary artery bypass graft (CABG) surgery, reoperative cardiac surgery, minimally invasive surgery, and transcatheter aortic valve replacement (TAVR).
Dr. Shudo is fully committed to innovative, comprehensive, and compassionate care for each patient he treats. -
Ann Shue, MD
Clinical Assistant Professor, Ophthalmology
Clinical Assistant Professor (By courtesy), PediatricsBio**Dr. Shue is taking new patients for glaucoma, cataracts, and adult strabismus.**
Ann Shue, MD, is a Clinical Assistant Professor of Ophthalmology at Stanford University School of Medicine, where she specializes in glaucoma, pediatric ophthalmology, and adult strabismus, a unique combination of subspecializations practiced by few surgeons worldwide. She is a board-certified ophthalmologist who completed fellowships in glaucoma at Yale University and pediatric ophthalmology and adult strabismus at Duke University. She practices at the Stanford Byers Eye Institute and the Lucile Packard Children's Hospital.
Dr. Shue loves seeing patients of all ages with eye problems big or small, including glaucoma due to any reason, glaucoma suspicion, family history of glaucoma, cataracts, strabismus (eye misalignment) or double vision from any cause, including after eye surgeries. She completed her ophthalmology residency at the University of Pittsburgh and an internal medicine internship at UCSF Fresno. She holds a medical degree from University of California, Irvine and an undergraduate degree in biology from Yale University.
Dr. Shue is a member of the American Glaucoma Society, the American Association for Pediatric Ophthalmology and Strabismus, and the UK Paediatric Glaucoma Society. She is active in presenting at regional and national conferences. She is the author of several journal articles and recently wrote two textbook chapters on pediatric glaucoma and pediatric glaucoma surgery. -
Lawrence Shuer, MD
Professor of Neurosurgery
Current Research and Scholarly InterestsI have clinical research interests in the surgical treatment of epilepsy. I am also interested in new developments in the treatment of craniosynostosis a congenital abnormality of infant's skulls
-
Takudzwa Shumba
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Takudzwa Shumba is a family medicine clinician-educator with particular interests in global health equity, preventative medicine, women's health, pediatrics and integrative medicine. She was born and raised in Zimbabwe. Prior to beginning medical school at Stanford, she completed a Master's in Public Health at Yale, with a focus in global health. She has been involved in public health projects in Zimbabwe, Hong Kong and mainland China and Kenya. She completed her residency at Stanford Health Care - O'Connor Hospital Family Medicine in San Jose, prior to joining faculty at Stanford Family Medicine. LGBTQQI friendly. After several years as a continuity primary care provider at Stanford Family Medicine, she transitioned to providing quality same day access for acute patient needs.
She is currently Co-director of the Leadership Education in Advancing Diversity (LEAD) program, Associate Director of the Clinical Summer Internship (CSI), Course Director of the undergraduate seminar “Decolonizing Global Health,” and Co-Director of the "Social and Environmental Determinants of Health" elective. She is a California Health Care Foundation (CHCF) Fellow (2020-2022) and Presidential Leadership Scholar (2022). She previously served as the Primary Care and Population Health (PCPH) Division Global Health faculty lead and PCPH DEI faculty lead. -
Anjali Sibley MD, MPH
Clinical Associate Professor, Medicine - Oncology
BioDr. Sibley is a Clinical Associate Professor of Medicine (Oncology) at Stanford School of Medicine. She is the Director of the Stanford Medicine Cancer Center in Emeryville and is a board-certified, fellowship-trained hematologist and medical oncologist.
Her clinical interests include treating solid tumor cancers, lung cancers, blood cancers and benign blood conditions. She is interested in cancer prevention and reducing disparities in hematologic/oncologic care among underserved populations, and successful cancer survivorship programs.
In addition to responsibilities related to patient care and overseeing the Cancer Center in Emeryville, Dr. Sibley has developed and is leading an innovative cancer survivorship clinic, including an exercise initiative. She also is passionate about advancing clinical trial enrollment for medically underserved populations and she serves on the Cancer Network’s East Bay Health Equity Committee leading lung cancer screening efforts in the East Bay. She is also working on a Stanford Cancer Institute-funded study examining psychosocial factors and cardiac health in Black cancer patients in the East Bay.
She believes that providing patient care is a true privilege. Dr. Sibley utilizes a patient-centered practice approach that addresses multiple aspects of a patient’s well-being. Her research interests have included chemoprevention of breast cancer and the development of magnetic resonance imaging technology in breast cancer detection and mapping. She has also led community-based efforts to implement low-dose computed tomography (LDCT) as a screening tool for cancer.
Dr. Sibley’s publications include articles on breast cancer prevention, breast magnetic resonance imaging, and other topics. Her work has appeared in American Journal of Hematology, JAMA, the Breast Journal, Internal Medicine News, and elsewhere. Dr. Sibley was invited to deliver a peer-reviewed presentation on community-based cancer screening and preventive education to the Global Health Council. Dr. Sibley is on the board of directors of the Cancer Support Community SF Bay Area. She has also served as a clinic physician for the Native American Health Center of Oakland, on the Committee on Health Equity of the American Public Health Association, and as chair and vice chair of the Cancer Forum Caucus of the American Public Health Association. She is a member of the American Society of Clinical Oncology, American Society of Preventive Oncology, and American Society of Hematology. She has provided volunteer services to the Global Health Council and to the Cancer Patients Aid Association, for whom she conducted a patient screening and education program in Mumbai, India. -
Eric Sibley, M.D., Ph.D.
Professor of Pediatrics (Gastroenterology)
Current Research and Scholarly InterestsMolecular Regulation of Intestinal Development and Maturation. We study transcriptional mechanisms regulating the spatial and temporal restriction of intestine-specific gene expression during gut development. Our approach is to characterize the function of gene-specific DNA cis elements and interacting nuclear proteins in cell culture and in transgenic animals. The goal is to relate the gene-specific control mechanisms to the broader pathways specifying acquisition of gut phenotypes.
-
Richard Sibley
Professor of Pathology, Emeritus
Current Research and Scholarly InterestsImmunologic mechanism of rejection in humans and animal, models of organ transplantation; histological definition of clinical pathology studies of various renal disorders.
-
Surbhi Sidana, MD
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Surbhi Sidana is an Associate Professor of Medicine at Stanford University and specializes in the treatment of multiple myeloma and related disorders. She leads the Myeloma CAR-T/Immunotherapy program at Stanford.
Dr Sidana grew up in Delhi, India, where she completed her initial medical training. She then moved to the U.S and completed her Internal Medicine Residency at Cleveland Clinic in Cleveland, Ohio, followed by Hematology/Oncology fellowship at Mayo Clinic in Rochester, MN. Following this, she completed an Advanced Hematology Fellowship in Myeloma, Amyloidosis and Related Disorders at Mayo Clinic in Rochester, MN before joining Stanford University as a faculty member in 2019, where she has led the development of the myeloma CAR-T and bispecific antibody program.
Dr Sidana has an active, broad research portfolio that includes clinical trials of novel therapies in myeloma and related disorders, translational research, epidemiologic and patient reported outcome studies. She has a special focus on research with immunotherapies such as CAR-T cell therapy and bispecific antibodies. She has published over 80 research manuscripts. Dr Sidana is the Leader of the Myeloma Disease Focused Group and the Associate Director for Clinical Research in the BMT and Cell Therapy Division at Stanford University. She also co-leads a multi-institutional collaboration on real world outcomes with immunotherapies in myeloma.
Dr Sidana is actively involved in and holds leadership positions in national and international professional societies. She co-chairs the Quality-of-Life Committee of the International Myeloma Working Group and is the Vice-Chair of the American Society of Hematology Committee on Communications. She also a member of the ASH Editor Search Committee and the SWOG Myeloma Committee. -
Pradeep Kumar Siddappa, MD
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Pradeep Kumar Siddappa is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care. He is also a clinical assistant professor in the Department of Medicine, Division of Gastroenterology & Hepatology at Stanford University School of Medicine.
Dr. Siddappa specializes in advanced endoscopy procedures to diagnose and treat gastrointestinal conditions. He focuses on pancreatic care, including acute and chronic pancreatitis, pancreatic cysts, and pancreatic cancer. He uses advanced, minimally invasive methods to help detect pancreatic cancer early and treat people who cannot undergo surgery.
Dr. Siddappa has studied many gastrointestinal conditions over the years, garnering grant funding and several awards. His primary research examines pancreatic cancer and how to catch it earlier through biomarkers in the pancreatic cyst fluid. He also investigates ways to improve endoscopic and duodenoscopic technology. He has developed new endoscopic techniques for diagnosis and treatment, including endoscopic ultrasound-guided omental fine needle aspiration.
Dr. Siddappa has published his findings in peer-reviewed journals including the Journal of Gastrointestinal Cancer, Clinical Endoscopy, JGH Open, and the World Journal of Gastrointestinal Endoscopy. He has also shared his research and presented it at conferences around the world, including at the annual Digestive Diseases Week. He has covered topics including new diagnostic markers in pancreatic cyst fluid, narrow band imaging, hepatocellular carcinoma, and pancreatic ductal adenocarcinoma.
Dr. Siddappa is a member of the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. -
Douglas Sidell, MD
Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsDr. Sidell's clinical interests include the management of children with voice and swallowing disorders, and congenital or acquired airway abnormalities. Examples of ongoing or upcoming prospective trials include an investigation into the utility of acid suppression in children with laryngomalacia, the management of vocal cord paralysis following cardiac surgery, and the management of type 1 laryngeal clefts in children.
-
Arend Sidow
Professor of Pathology and of Genetics
Current Research and Scholarly InterestsWe have a highly collaborative research program in the evolutionary genomics of cancer. We apply well-established principles of phylogenetics to cancer evolution on the basis of whole genome sequencing and functional genomics data of multiple tumor samples from the same patient. Introductions to our work and the concepts we apply are best found in the Newburger et al paper in Genome Research and the Sidow and Spies review in TIGS.
More information can be found here: http://www.sidowlab.org -
Allison Tamara Siebern
Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Allison Siebern, PhD, DAc, LAc, CBSM is a sleep medicine psychologist and neuroscience-based doctor of acupuncture specializing in sleep, mood, and neurological health. She is board certified in Behavioral Sleep Medicine by the American Board of Sleep Medicine.
Dr. Siebern is a pioneer in the field of integrative sleep health as she blends her training and expertise in neuroscience-based acupuncture, cognitive behavioral medicine, psychophysiology, near-infrared transcranial photobiomodulation and clinical neuroscience. Dr. Siebern's current integrative health research is on the intersection of scalp acupuncture and near-infrared transcranial photobiomodulation (tPBM) as neuromodulatory mechanisms to assist in improved symptom outcomes in neurodegenerative disorders and post-stroke recovery.
Dr. Siebern is currently a Sleep Medicine Psychologist and Behavioral Sleep Medicine Fellowship Track Director with the Durham VA Medical Center and the Director of Integrative Sleep Wake Health, PLLC. Dr. Siebern is an Adjunct Clinical Associate Professor at Stanford University School of Medicine in the Sleep Medicine Division where she completed the sleep fellowship from 2008 to 2010 and stayed on as full-time faculty until 2015 where she served as Associate Director and Co-Fellowship Training Director and then Director of the Behavioral Sleep Medicine Program. She has been treating patients of all ages in the field of sleep medicine for 15 years. She consults with companies on sleep and neurological health science, is published in peer-reviewed journals, has given talks at national conferences, and has been interviewed with many media outlets. Dr. Siebern has a passion for the field of sleep health and believes in the importance of training future generations of sleep providers. -
Dawn H. Siegel, MD
Clinical Professor, Dermatology
Clinical Professor (By courtesy), PediatricsCurrent Research and Scholarly InterestsI'm dedicated to connecting patients with clinical research trials and contributing to research on specific skin conditions particularly hemangiomas, birthmarks, and PHACE syndrome. My research also aims to develop solutions to health disparities through improved access to pediatric dermatologists and treatments.
-
Robert Siegel
Professor (Teaching) of Microbiology and Immunology
Current Research and Scholarly InterestsMy work is primarily involved in medical education and curricular development, especially in the areas of infectious disease, virology, HIV, and molecular biology. Projects included electronic applications to science education, three dimensional model building, service learning, and the development of undergraduate research projects.
